This company has shut down. Kintara Therapeutics is no longer operating — its last tracked round was a Grant in 2023.
Explore the Startup GraveyardKintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.
Kintara Therapeutics has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in June 2023.
Kintara Therapeutics's investors include National Institutes of Health, SternAegis, Lincoln Park Capital Fund, Luxembourg National Research Fund.
Kintara Therapeutics is headquartered in Vancouver, Canada.
Kintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.
Kintara Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kintara Therapeutics — Funding & Investors." VCBacked, June 28, 2023, https://www.vcbacked.co/company/kintara-therapeutics. Accessed July 19, 2026.
VCBacked. (2023). Kintara Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/kintara-therapeutics
{{cite web |title=Kintara Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kintara-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated